Browse > Article

Anti-inflammatory Effect of Boswellia sacra (Franckincense) Essential Oil in a Mouse Model of Allergic Asthma  

Lee, Hye-Youn (Department of Bioengineering Graduate School at Konkuk University)
Yun, Mi-Young (Department of Beauty Health Care, Daejeon University)
Kang, Sang-Mo (Department of Bioengineering Graduate School at Konkuk University)
Publication Information
Microbiology and Biotechnology Letters / v.36, no.4, 2008 , pp. 343-352 More about this Journal
Abstract
Frankincense, the gum resin derived from Boswellia species, is complex mixtures composed of about $5{\sim}9%$ highly aromatic essential oil, $65{\sim}85%$ alcohol-soluble resins, and the remaining water-soluble gums. The anti-inflammatory properties of frankincense, alcohole-soluble resins, are well-recognized, but the question of whether aromatic essential oil also plays a role in the allergic asthma remains unanswered. This study was performed to evaluate anti-inflammatory effects of Boswellia sacra essential oil (BSEO) on ovalbumin (OVA)-induced asthma mouse model. BALB/c mice after intraperitoneal OVA sensitization were challenged with intratracheal OVA. One experimental group was inhaled with 0.3% BSEO for the later 8 weeks. BALB/c mice were sensitized and challenged with OVA and developed airway eosinophilia, mucus hypersecretion, and airway hyperresponsiveness. In contrast, the BSEO treated mice had reduced a number of eosinophils among BALF cells, goblet cell hyperplasia, and airway hyperresponsiveness. Cytokine analysis of BALF revealed that BSEO caused an increase in Th1 cytokine (interferon-$\gamma$ (IFN-$\gamma$)) and a decrease in Th2 cytokines (interleukin-4 (IL-4), IL-5 and IL-13) levels. In addition, the OVA-specific serum IgE and eotaxin levels were also reduced. In mice inhaled BSEO, $CD4^+$, $CD3^+/CCR3^+$, and $B220^+/CD23^+$ mediastinal lymph nodes cells were also decreased. These results suggest that inhaled BSEO as a immunomodulator in Th1/Th2 mediated asthma may have therapeutic potential for the treatment in allergic airway inflammation by a simple, cost-effective way.
Keywords
Boswellia sacra; frankincense; essential oil; allergic asthma; airway inflammation;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
1 Aronica, M. A., S. McCarthy, S. Swaidani, D. Mitchell, M. Goral, J. R. Sheller, and M. Boothby. 2004. Recall helper T cell response: T helper 1 cell-resistant allergic susceptibility without biasing uncommitted CD4 T cells. Am. J. Respir. Crit. Care Med. 169: 587-595   DOI   ScienceOn
2 Barnes, P. J. 2000. Endogenous inhibitory mechanisms in asthma. Am. J. Respir. Crit. Care Med. 161: S176-181   DOI
3 Borish, L. 2003. Allergic rhinitis: Systemic inflammation and implications for management. J. Allergy Clin. Immunol. 112: 1021-1031   DOI   ScienceOn
4 de Heer, H. J., H. Hamida, S. Thomas, J. Danielle, V. Nanda, A. M. W. Monique, C. H. Henk, and N. L. Bart. 2004. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 5: 89-98
5 de Sousa, A. C., D. S. Alviano, A. F. Blank, P. B. Alves, C. S. Alviano, and C. R. Gattass. 2004. Melissa officinalis L. essential oil: antitumoral and antioxidant activities. J. Pharm. Pharmacol. 56: 677-681   DOI   ScienceOn
6 Duan, W., J. H. Chan, C. H. Wonq, B. P. Leung, and W. S. Wonq. 2004. Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J. Immunol. 172: 7053-7059   DOI   PUBMED
7 Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Mattaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201   DOI   ScienceOn
8 Huang, M. T., V. Badmaev, Y. Ding, Y. Liu, J. G. Xie, and C. T. Ho. 2000. Anti-tumor and anti-carcinogenic acitivity of triterpenoid, beta boswellic acid. Biofactors. 13: 225-230   DOI
9 Kibe, A., H. Inoue, S. Fukuyama, K. Machida, K. Matsumoto, H. Koto, T. Ikeqami, H. Aizawa, and N. Hara. 2003. Differential regulation by glucocorticoid of interleukin- 13-induced eosinophilia: hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am. J. Respir. Crit. Care Med. 167: 50-56   DOI   ScienceOn
10 Kim, J., H. Lee, Y. Lee, B. G. Oh, C. Cho, Y. Kim, M. Shin, M. Hong, S. K. Jung and H. Bae. 2007. Inhibition effects of Moutan Cortex Radicis on secretion of eotaxin in A549 humna epithelial cells and eosinophil migration. J. Ethnopharmacol. 114: 186-193   DOI   ScienceOn
11 Maruyama, N., Y. Sekimoto, H. Ishibashi, S. Inouye, H. Oshima, H. Yamaquchi, and S. Abe. 2005. Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil. J. Inflamm. (Lond). 2: 1-11   DOI   ScienceOn
12 Paul, J. B., G. Raif, and C. O. Hans. 2003. Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. J. Allergy Clin. Immunol. 112: 149-159   DOI   ScienceOn
13 Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoalveolar Tlymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304   DOI   PUBMED   ScienceOn
14 Taube, C., C. Duez, Z. H. Cui, K. Takeda, Y. H. Rha, J. W. Park, A. Balhorn, D. D. Donaldson, A. Dakhama, and E. W. Gelfand. 2002. The role of IL-13 in established allergic airway disease. J. Immunol. 169: 6482-6489   DOI   PUBMED
15 Roh, G. S., S. W. Seo, S. Yeo, J. M. Lee, J. W. Choi, E. Kim, Y. Shin, C. Cho, H. Bae, S. K. Jung, and K. Kwack. 2005. Efficacy of a traditional Korean medicine, Chung-Sang-Bo- Ha-Tang, in a murine model of chronic asthma. Int. Immunopharmacol. 5: 427-436   DOI   ScienceOn
16 Singh, G. B., S. Singh, and S. Bani. 1996. Anti-inflammatroy actions of boswellic acids. Phytomedicine 3: 81-85   DOI   ScienceOn
17 Takami, M., Y. Takata, K. Matsumoto, S. Ono, and W. Tsukada. 1991. Effects of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma. Ann. N. Y. Acad. Sc. 629: 407-409   DOI
18 van Schayck, C. P., I. D. Bijl-Hofland, S. G. Cloosterman, H. T. Folqering, F. J. vad der Elshout, and C. Van Weel. 2002. Potential masking effect on dyspnoea perception by shortand long-acting beta2-agonists in asthma. Eur. Respir. J. 19: 240-245   DOI   ScienceOn
19 Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, J. C. Jr. Virchow. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveloar lavage. Am. Rev. Respir. Dis. 146: 109-115   DOI   PUBMED   ScienceOn
20 Redington, A. E., and P. H. Howarth. Airway wall remodeling in asthma. Thorax. 52: 310-312   DOI   PUBMED   ScienceOn
21 Yang, M., S. P. Hogan, S. Mahalingam, S. M. Pope, N. Zimmermann, P. Fulkerson, L. A. Dent, I. G. Young, K. I. Mattaei, M. E. Rothenberg, and P. S. Foster. 2003. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J. Allergy. Clin. Immunol. 112: 935-943   DOI   ScienceOn
22 Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, and A. Sirotina. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183: 2349-2354   DOI   ScienceOn
23 Bousquet, J., P. Chanez, J. Y. Lacoste, R. White, P. Vic, P. Godard, and F. B. Michel. 1992. Asthma: a disease remodeling the airways. Allergy. 47: 3-11   PUBMED
24 Palmerio, E. M., R. J. Hopp, R. E. Biven, A. K. Bewtra, N. N. Nair, and R. G. Townley. 1992. Probability of asthma based on methacholine challenge. Chest. 101: 630-633   DOI   ScienceOn
25 Roche, W. R., R. Beasley, J. H. Wiliams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1: 520-524   PUBMED
26 Barnes, P. J. 1999. Therapeutic strategy for allergic disease. Nature. 402: B31-38 (Suppl.)
27 Busse, W. W., and R. F. Jr. Lemanske. 2001. Asthma. N. Engl. J. Med. 344: 350-362   DOI   ScienceOn
28 Won, J., Y. G. Hur, E. M. Hur, S. H. Park, M. A. Kang, Y. Choi, C. Park, K. H. Lee, and Y. Yun. 2003. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner. Eur. J. Immunol. 33: 870-879   DOI   ScienceOn
29 Bousquet, J., P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. 2000. Asthma, From bronchoconstriction to airway inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161: 1720-1745   DOI   PUBMED   ScienceOn
30 Tucker, A. O., 1986. Frankincense and myrrh. Econ. Bot. 40: 425-433   DOI
31 Bromberg, J. S. 1993. The biology of CD2: adhesion, transmembrane signal, and regulatory receptor of immunity. J. Surg. Res. 54: 258-267   DOI   ScienceOn
32 Roy, S., S. Khanna, H. Shah, C. Rink, C. Phillips, H. Preuss, G. V. Subbaraju, G. Trimurtulu, A. V. Krishnaraju, M. Baqchi, D. Baqchi, and C. K. Sen. 2005. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. 24: 244-255   DOI   ScienceOn
33 Scola, A. M., L. K. Chong, S. K. Suvarna, R. Chess-Williams, and P. T. Peachell. 2004. Desensitisation of mast cell beta2- adrenorceptor-mediated responses by salmeterol and formoterol. Br. J. Pharmacol. 141: 163-171   DOI   ScienceOn
34 Abe, S., N. Maruyama, K. Hayama, H. Ishibashi, S. Inoue, H. Oshima, and H. Yamaguchi. 2003. Suppression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils. Med. Inflamm. 12: 323-328   DOI   ScienceOn
35 Cookson, W. 1999. The alliance of genes and environment in asthma and allergy. Nature. 402: B5-11 (Suppl.)   PUBMED
36 Hamm, S., J. Bleton, J. Connan, and A. Tchapla. 2005. A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples. Phytochemistry. 66: 1499-1514   DOI   ScienceOn
37 Erin, E. M., T. J. Williams, P. J. Barnes, and T. T. Hansel. 2002. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. Curr. Drug Targets Inflamm. Allergy. 1: 201-214   DOI
38 Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Cirt. Care. Med. 156: 766-775   DOI   ScienceOn
39 Yang, S. H., C. Y. Hong, and C. L. Yu. 2001. Decreased serum IgE level, decreased IFN-r and IL-5 but increased IL- 10 production, and suppressed cyclooxygenase 2 mRNA expression in patients with perennial allergic rhinitis after treatment with a new mixed formula of Chinese herbs. Int. Immunopharmacol. 1: 1173-1182   DOI   ScienceOn
40 Gupta, I., V. Gupta, A. Parihar, S. Gupta, R. Lüdtke, H. Safayhi and H. P. Ammon. 1998. Effect of Boswellia serrata gum resin in patients with bronchial asthma: results of a double blind, placebo-control, 6-week clinical study. Eur. J. Med. Res. 3: 511-514   PUBMED
41 Sharma, M. L., A. Kaul, A., Khajuria, S. Singh, and G. B. Singh. 1996. Immunomodulatory activity of boswellic acids (pentacyclic triterpene acids) from Boswellia serrata. Phytother. Res. 10: 107-112   DOI
42 Gleich, G. J. 2000. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 105: 651-663   DOI   ScienceOn
43 Jain, V. V., K. Kitaqaki, T. Businqa, I. Hussain, C. Geroge, P. O'shauqhnessy, and J. N. Kline. 2002. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J. Allergy Clin. Immunol. 110: 867-872   DOI   ScienceOn
44 Makino, S., and T. Fukuda. 1995. Eosinophils and allergy in asthma. Allergy Proc. 16: 13-21
45 Coyle, A. J., C. Bertrand, S. Tsuyuki, H. Pircher, S. Walti, G. Le Gros, and F. Erard. 1996. IL-4 differentiates naive CD8+ T cells to a "Th2-like" phenotype: a link between viral infections and bronchial asthma. Ann. N. Y. Acad. Sci. 796: 97-103   DOI
46 Marco, I., H. Hamida, M. van Nimwegen, K. Mirjam, V. Nanda, C. H. Henk, and N. L. Bart. 2006. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J. Clin. Invest. 116: 2935-2944   DOI   ScienceOn
47 Marx, J., E. Pretorius, and M. J. Bester. 2006. Effects of Urginea sanguinea, a traditional asthma remedy, on embryo neuronal development. J. Ethnopharmacol. 104: 315-321   DOI   ScienceOn
48 Takayuki, N., A. Yumiko, E. Michiko, N. Shin-yu, Y. Takeshi, and Y. Haruki. 2004. Anti-allergic acitivity of a Kampho (Japanese herbal) medicine "Sho-seiryu-to (Xiao- Qing-Long-Tang)" on airway inflammation in a mouse model. Int. Immunopharmacol. 4: 1353-1365   DOI   ScienceOn
49 Y., M. Dohi, R. Tanaka, A. Sato, K. Nakaqome, and K. Yamamoto. 2001. Early interleukin 4-dependent response can induce ariway hyperreactivity before development of airway inflammation in a mouse model of asthma. Lab. Invest. 81: 1385-1396   DOI   ScienceOn
50 Ram, A., U. Mabalirajan, M. Das, I. Bhattacharya, A. K. Dinda, S. V. Ganqal and B. Ghosh. 2006. Glycyrrhizin alleviates experimental allergic asthma in mice. Int. Immunopharmacol. 6: 1468-1477   DOI   ScienceOn
51 Larché, M., D. S. Robinson, and A. B. Kay. 2002. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 111: 450-463
52 Garside, P., M. Steel, E. A. Worthey, A. Satoskar, J. Alexander, H. Bluethmann, F. Y. Liew, and A. M. Mowat. 1995. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154: 5649-5655   PUBMED
53 Kung, T. T., D. Stelts, J. A. Zurcher, A. S. Watnick, H. Jones, P. J. Mauser, X. Fernandez, S. Umland, and W. Kreutne. 1994. Mechanisms of allergic pulmonary eosinophilia in the mouse. J. Allergy Clin. Immunol. 94: 1217-1224   DOI   ScienceOn
54 Roitt, I. M., J. Brostoff, and D. Male. 1989. Immunology. pp. 11-20. 2nd ed. Gower medical Publishing, London
55 Vignola, A. M., P. Chanez, A. M. Campbell, F. Souques, B. Lebel, I. Enander, and J. Bousquet. 1998. Airway inflammation in mild intermittent and in persistent asthma. Am. J. Respir. Crit. Care Med. 157: 403-409   DOI   PUBMED   ScienceOn
56 Barnes. P. J. 1999. Effect of bbb2-agonist on inflammatory cells. J. Allergy Clin. Immunol. 104: 10-17   DOI   ScienceOn
57 Hajhashemi, V., A. Ghannadi, and B. Sharif. 2003. Antiinflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill. J. Ethnopharmacol. 89: 67-71   DOI   ScienceOn
58 Kay, A. B., S. Ying, and S. R. Durham. 1995. Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reaction. Int. Arch. Allergy Immunol. 107: 208-210   DOI   ScienceOn
59 Hart, P. H., C. Brand, C. F. Carson, T. V. Riley, R. H. Prager, and J. J. Finaly-Jones. 2000. Terpinen-4-ol, the main component of the essential oil of Melalecuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm. Res. 49: 619-626   DOI
60 Kasakura, S. 1998. A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human disease. Rinsho. Byori. 46: 915-921   PUBMED